It should also build a portfolio of strong brands rather than just rel
ying on a single drug as its lifeline. According to an industry analyst this is a common mistake as he opines, “...in big companies (like Pfizer), relying on a single drug is common...” With Pfizer’s plan to reduce sales force by 20%, only one thing remains to be said – the problem lies with ‘what’ is sold and not with ‘how many’ sell it! And is it forgetting that investing ‘blindly’ in R&D only means destruction? Certainly, Pfizer should master the art of following the right strategic leads, if there’s to be a healthier tomorrow!
For Complete IIPM Article, Click on IIPM Article
ying on a single drug as its lifeline. According to an industry analyst this is a common mistake as he opines, “...in big companies (like Pfizer), relying on a single drug is common...” With Pfizer’s plan to reduce sales force by 20%, only one thing remains to be said – the problem lies with ‘what’ is sold and not with ‘how many’ sell it! And is it forgetting that investing ‘blindly’ in R&D only means destruction? Certainly, Pfizer should master the art of following the right strategic leads, if there’s to be a healthier tomorrow!For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2006
An IIPM and Management Guru Professor Arindam Chaudhuri's Initiative
Rashmi Bansal Publisher Of JAMMAG Magazine Caught Red-Handed, for details click on the following links.
- Hindustan Times Article - Publisher goes underground
- Rashmi Bansal (Editor of JAMMAG)
- Rashmi Bansal (Publisher of JAMMAG)
posted by IIPM @ 1:24 AM
0 Comments:
Post a Comment
<< Home